Cyblex MV

✅ Manages blood sugar
✅ Triple action formula
✅ Controls diabetes effectively
✅ Combination therapy
✅ Improves insulin sensitivity

Cyblex MV contains Metformin, Gliclazide and Voglibose.

Product Overview

Cyblex MV is a medication formulated with a combination of active ingredients including Metformin, Gliclazide, and Voglibose. This combination medication is designed to effectively manage blood sugar levels in individuals with type 2 diabetes mellitus. Cyblex MV works through multiple mechanisms to regulate blood glucose, improve insulin sensitivity, and inhibit the absorption of sugars in the intestines. It is available in tablet form and is prescribed to provide comprehensive control over diabetes management.


Cyblex MV is primarily used for the treatment of type 2 diabetes mellitus. It helps to lower blood sugar levels by decreasing hepatic glucose production, enhancing insulin secretion, and reducing insulin resistance. This medication is prescribed to individuals whose blood sugar levels are not adequately controlled by diet and exercise alone. Cyblex MV may also be used as part of a combination therapy regimen alongside other antidiabetic medications to achieve optimal glycemic control.

How to Use

Cyblex MV tablets should be taken orally with meals to reduce the risk of gastrointestinal side effects. Swallow the tablets whole with a full glass of water; do not crush, chew, or break them. The dosage and frequency of administration will be determined by a healthcare provider based on individual patient factors such as blood sugar levels, response to treatment, and concurrent medications. It is important to follow the prescribed dosage instructions and not to exceed the recommended dose.

How it Works

Metformin, Gliclazide, and Voglibose, the active ingredients in Cyblex MV, work synergistically to control blood sugar levels through different mechanisms. Metformin primarily reduces hepatic glucose production and increases peripheral glucose uptake. Gliclazide stimulates insulin secretion from pancreatic beta cells, while Voglibose inhibits alpha-glucosidase enzymes in the intestines, slowing down the digestion and absorption of carbohydrates.

Dosage and Administration

The dosage of Cyblex MV is individualized based on factors such as the severity of diabetes, renal function, and response to treatment. The usual starting dose is one tablet taken orally with each meal. Dosage adjustments may be necessary based on glycemic control and tolerability. It is important to adhere to the prescribed dosage regimen and to continue monitoring blood sugar levels regularly. Do not discontinue Cyblex MV without consulting a healthcare provider.


Cyblex MV offers several benefits for individuals with type 2 diabetes, including effective blood sugar control, reduced risk of diabetes-related complications, and improved overall quality of life. By targeting multiple pathways involved in glucose metabolism, Cyblex MV provides comprehensive glycemic control and helps to prevent hyperglycemia and its associated symptoms. Additionally, this combination medication may contribute to weight loss and improve cardiovascular health in some individuals.

Common Side Effects

Common side effects of Cyblex MV may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, abdominal discomfort, and bloating. These side effects are usually mild and transient, resolving on their own as the body adjusts to the medication. In rare cases, Cyblex MV may cause hypoglycemia (low blood sugar), particularly when used in combination with other antidiabetic medications.


Cyblex MV should be used with caution in individuals with renal impairment, as it may increase the risk of lactic acidosis. It is important to monitor kidney function regularly while taking Cyblex MV. This medication may also interact with certain medications, so it is essential to inform a healthcare provider about all current medications and medical conditions before starting treatment. Cyblex MV is contraindicated in individuals with severe renal impairment, hepatic impairment, or a history of hypersensitivity to any of the components.

Storage Information

Cyblex MV should be stored at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Do not use Cyblex MV after the expiration date printed on the packaging. If unsure about how to dispose of unused or expired medication, consult a pharmacist or healthcare provider for guidance.


Our sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions, or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.


500+80+0.2 mg


30 Tablet/s, 60 Tablet/s, 90 Tablet/s, 180 Tablet/s


There are no reviews yet.

Be the first to review “Cyblex MV”